Skip to main content
logo
MeVis Medical Solutions AG (ETR:M3V)
Germany flag Germany · Delayed Price · Currency is EUR
23.60
0.00 (0.00%)
Aug 5, 2026, 5:35 PM CET

ETR:M3V Cash Flow Statement

Millions EUR. Fiscal year is Oct - Sep.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Income
3.174.564.927.794.55
Depreciation & Amortization
0.150.130.10.090.13
Other Adjustments
-0.73-1.7-0.67-0.680.22
Change in Receivables
0.640.571.58-1.913.9
Changes in Accounts Payable
0.76-0.130.05-0.270.34
Changes in Income Taxes Payable
-0.11-0.29-0.12-0.17-0
Changes in Other Operating Activities
1.091.21.070.190.16
Operating Cash Flow
3.883.155.854.869.13
Operating Cash Flow Growth
23.29%-46.25%20.52%-46.80%215.97%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Capital Expenditures
-0.14-0.3-0.08-0.13-0.05
Proceeds from Sale of Investments
00.010--
Investing Cash Flow
0.950.910.990.060.11

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Common Dividends Paid
-4.56-4.92-7.79-4.55-5.7
Financing Cash Flow
-4.56-4.92-7.79-4.55-5.7

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Foreign Exchange Rate Adjustments
-0.27-0.35-0.631.330.13
Net Cash Flow
0.26-0.87-0.940.373.54

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Free Cash Flow
3.742.845.774.729.08
Free Cash Flow Growth
31.44%-50.74%22.23%-47.97%225.78%
FCF Margin
23.28%16.76%33.30%25.18%56.00%
Free Cash Flow Per Share
2.051.563.172.604.99
Levered Free Cash Flow
-1.42-3.96-3.91-8.07-3.97
Unlevered Free Cash Flow
9.269.8611.029.119.86